0001415889-24-006310.txt : 20240304 0001415889-24-006310.hdr.sgml : 20240304 20240304172409 ACCESSION NUMBER: 0001415889-24-006310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Markel Stacy CENTRAL INDEX KEY: 0001734780 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39351 FILM NUMBER: 24716020 MAIL ADDRESS: STREET 1: RIGEL PHARMACEUTICALS, INC. STREET 2: 1180 VETERANS BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvation Bio Inc. CENTRAL INDEX KEY: 0001811063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850862255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 754-3517 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Panacea Acquisition Corp DATE OF NAME CHANGE: 20200430 4 1 form4-03042024_100304.xml X0508 4 2024-02-29 0001811063 Nuvation Bio Inc. NUVB 0001734780 Markel Stacy C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 false true false false CHIEF PEOPLE OFFICER 0 Class A Common Stock 10591 D Stock Option (Right to Buy) 1.87 2024-02-29 4 A 0 500000 0 A 2034-02-27 Class A Common Stock 500000 500000 D Includes 3,000 shares acquired on May 19, 2023 and 3,000 shares acquired on November 17, 2023 under the Issuer's 2021 Employee Stock Purchase Plan. Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. /s/ Ron A. Metzger, Attorney-in-Fact 2024-03-04